Artificial Insemination Market New Advancement Helps to Achieve US$ 2,017.6 Million by Top Key Players till 2027 | Pride Angel, Irvine Scientific, Hi-Tech Solutions

Global Artificial Insemination Market

Artificial insemination is a medical process involving the deliberate introduction of sperm into a female mammal’s uterus for the purpose of impregnating or fertilizing her for sexual reproduction. It is primarily a fertility treatment process for humans, and is a usual practice for animal breeding. Recipients of artificial insemination include single mothers and infertile couples. Intrauterine Insemination (IUI) is the most widely operated method of artificial insemination. Increasing prevalence of reproductive infertility is an indispensable factor contributing to the growth of the global artificial insemination market. According to a research paper published in PLOS Medicine, in 2010, around 48.5 million couples worldwide were unable to conceive a child. These days, various home-use kits, including ovulation kits, pregnancy detection kits, and insemination devices, are available globally for couples.

𝐓𝐨 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/1793

Global Artificial Insemination Market Dynamics

Numerous pharmaceutical companies around the world have been actively developing new products like insemination kits, some of which are currently undergoing clinical and preclinical trials. This, in turn, is propelling the growth of the global artificial insemination market. For instance, a 2015 clinical trial of Stork OTC kit showed effectiveness at delivering higher concentrations of sperm to the cervix as compared to natural intercourse. The Stork OTC delivered an around three times higher value of sperm concentration to up to 85% of the subjects participating in the study, whereas, the remaining 15% showed no change in sperm concentration at the cervix. The device, which received an over-the-counter approval from the FDA in July 2014, provides a safe and simple way for users to deliver the sperm, avoiding an unfavorable vaginal environment.

As per the National Women’s Health Resource Center, infertility impacts over 20 million women across the globe. In the 2017 United Nations World Population Prospects report, it was speculated that the total fertility rate would decrease from 2.43 to 2.39 (children per woman) between the years 2020 and 2030. Rising incidence of infertility is majorly boosting the global artificial insemination market expansion.

𝐓𝐨 𝐆𝐞𝐭 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 –https://www.coherentmarketinsights.com/insight/request-sample/1793

However, stringent regulations regarding fertility treatments, which are being implemented across several countries, is a significant factor hampering the global market growth. For instance, Italy and France forbid single women from using artificial insemination devices. Moreover, Norway and Germany have strictly prohibited egg donations; however, sperm donations are allowed in these countries.

Global Artificial Insemination Market – Regional Insights

The North America market holds the dominant position in the global artificial insemination market, owing to technological advancements and favorable rules and regulations in the region. For instance, according to 2018 National Conference of State Legislature report, 14 states have laws mandating that employers offer insurance for fertility treatment. Hawaii, Arkansas, Texas, and Maryland mandate coverage for in vitro fertilization only, excluding inseminations.

Furthermore, the Asia Pacific artificial insemination market is projected to witness significant growth owing to increasing prevalence of infertility among the populace and less stringent regulations. For instance, according to the United Nation Department of Economic and Social Affairs 2015 report shows a fertility rate decline from 1.3 to 1.4 children per woman.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐫 𝐐𝐮𝐞𝐫𝐲 𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐛𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠, 𝐕𝐢𝐬𝐢𝐭 𝐚𝐭 – https://www.coherentmarketinsights.com/insight/talk-to-analyst/1793

Global Artificial Insemination Market – Competitive Landscape

The key players operating in the global artificial insemination market include Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pvt. Ltd. These players have been adopting various growth strategies, such as collaborations, acquisitions, and new product launches, to maintain their positions in the global market. For instance, in 2016, Worthington Industries, in collaboration with Intellectual Ventures, launched the innovative AIS 3 and AIS 1.5 artificial insemination shield refrigerators equipped with the advanced artificial insemination shield canisters for holding samples.

Market Taxonomy

On the basis of procedure type, the global artificial insemination market is segmented into:
• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Based on product type, the global artificial insemination market is bifurcated into:
• Insemination Kits
• Home Conception Devices
• Accessories

The global artificial insemination market comprises various end users, such as:
• Hospitals
• Clinics
• Fertility Centers
• Others

The global artificial insemination market is geographically segmented into:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

𝐓𝐨 𝐃𝐢𝐫𝐞𝐜𝐭 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 –https://www.coherentmarketinsights.com/insight/buy-now/1793

Contact US:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.